Search for: "Gene Hoffman" Results 21 - 40 of 50
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2013, 10:03 pm by James Andrews
Critics are also concerned that the GE salmon would outcompete wild varieties if its genes ever made it to open waters. [read post]
28 Feb 2012, 2:38 am by Lawrence Higgins
Google, Hoffman-LaRoche, Intel, Pfizer and BP will speak about their collaborations. [read post]
23 Feb 2012, 1:01 pm by Eric Hoffman
By Eric Hoffman As part of the ACLU's Taking Back Our Genes campaign, guest blogger Eric Hoffman, Policy Campaigner, Friends of the Earth, discusses the danger of gene patents. [read post]
6 Jul 2011, 2:21 am by Marie Louise
(Patent Baristas) US: FDA’s Chief Counsel, Ralph Tyler, set to leave FDA (FDA Law Blog) US: Docs at BIO: Steve Burrill’s state of the biotechnology industry report 2011 (Patent Docs) US: Counterfeiting: White House IP Czar Victoria Espinel on working with corporations (BIOtechNOW) US: Banning gene patents will promote innovation? [read post]
29 Dec 2010, 2:57 am by Marie Louise
Pfizer Ltd (Kluwer Patent Blog) Boniva (Ibandronate) – US: Roche dodges Cobalt invalidity contention in Boniva patent suit (Patent Docs) Boniva (Ibandronate) – US: Hoffman-La Roche files patent infringement suit against Mutual Pharmaceutical Company following Para IV certification filing (Patent Docs) Botox (Botulinum) – EU: General Court confirms declarations of invalidity of BOTOLIST and BOTOCYL filed by Allergan: T-345/08 and T-357-08 (Class 46) Detrol (Tolterodine)… [read post]
10 Nov 2010, 1:11 am by Kelly
Becton-Dickinson (Patent Docs) US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) US: BIO and AUTM fire back at gene patent foes – AMP v USPTO (Patent Baristas) (Patent Docs) US: IPO files amicus brief in AMP v USPTO (Patent Docs) (Patent Baristas) US: AIPLA submits amicus brief in AMP v USPTO (Patent Docs) US: Summary of Myriad patent claims… [read post]
10 Sep 2010, 8:07 am by Bexis
We're talking about the Restatement (Third) of Torts, Products Liability §2, to be precise. [read post]
9 Jul 2010, 9:07 am by Eugene Volokh
Reader Gene Hoffman points out that the post below is from last year and not this one; very sorry I missed this — how embarrassing.] [read post]
11 Mar 2010, 12:28 pm by Stephen Albainy-Jenei
Related posts:A Divisional Patent Application By Any Other Name Is … Not A Divisional After Amgen tried to get a judgment against Hoffman-La Roche... [read post]
30 Dec 2009, 2:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Kenyan anti-counterfeiting law to face constitutional challenge (Michael Geist) (Afro-IP) Ecuadorian Government orders creation of public drug company (IP tango) Mircera (Erythropoietin) – US: Amgen and Hoffman–La Roche settle Mircera litigation (Patent Docs)   General Top Biotech stories of 2009… [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs)   Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO Laboratories Limited v. [read post]
11 Nov 2009, 4:02 am
(BiotechBlog) ‘Most important’ biodiversity access / benefit meeting (IP Watch) EU: Patentability of gene sequences and Directive 98/44 (JIPLP) EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) US: Mayo seeks Supreme Court review in Prometheus Labs case (Patent Docs) US: Follow-on biologics news briefs – No 9: Patient groups back Senate and House Committee FOB legislation; DelawareBio and BIO seek support of Delaware Delegation; CCPM asks… [read post]
11 Nov 2009, 4:02 am
(BiotechBlog) 'Most important' biodiversity access / benefit meeting (IP Watch) EU: Patentability of gene sequences and Directive 98/44 (JIPLP) EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) US: Mayo seeks Supreme Court review in Prometheus Labs case (Patent Docs) US: Follow-on biologics news briefs - No 9: Patient groups back Senate and House Committee FOB legislation; DelawareBio and BIO seek support of Delaware Delegation; CCPM asks Congress to… [read post]
11 Nov 2009, 4:02 am
(BiotechBlog) 'Most important' biodiversity access / benefit meeting (IP Watch) EU: Patentability of gene sequences and Directive 98/44 (JIPLP) EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) US: Mayo seeks Supreme Court review in Prometheus Labs case (Patent Docs) US: Follow-on biologics news briefs - No 9: Patient groups back Senate and House Committee FOB legislation; DelawareBio and BIO seek support of Delaware Delegation; CCPM asks Congress to… [read post]
11 Sep 2009, 3:34 am
Cornbelt Update is a weekly summary of news from Extension, government, and other attributable sources, focused on marketing, farm management, and other issues that are of interest to Midwestern farm owners and operators. [read post]
7 May 2009, 1:51 pm
""California is often a leader in so many ways, but our state lags badly in streamlining its firearms laws," said Gene Hoffman, Chairman of The Calguns Foundation. [read post]
20 Dec 2008, 6:23 pm
When he gets his chance, he gets his fuzzy butt kicked on the regs by Master Shifu (Dustin Hoffman) and the rest of his kung fu heroes, the Furious Five. [read post]
5 Dec 2008, 1:00 pm
(Holman's Biotech IP Blog) IP and genetically modified organisms: a fateful combination, activists say (Intellectual Property Watch) Australia: Gene patent delays diagnosis and treatment for babies with severe form of epilepsy: (Techdirt) Brazil: Brazilian draft law would curb expanded patents on pharmaceuticals (Intellectual Property Watch) (IP tango) EU: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight)… [read post]